THE COLLAPSE in the share price of Mainstay Medical earlier this month has seen million wiped off the company’s market capitalisation. However, the market overreaction could present opportunities for intrepid investors who are happy to take a long-term punt on the potentially lucrative medical device being developed by this Irish company. While the outcome of… Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!